http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2391106-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ada3883c7488ffee5dd584562f77aa16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-714
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
filingDate 2008-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2010-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9da6b3e27527cc28e04d488e50415be
publicationDate 2010-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2391106-C1
titleOfInvention Method of treating verterbroneurological and spinal pathology
abstract FIELD: medicine. ^ SUBSTANCE: invention relates to medicine, namely to neurology and orthopedics, and can be used in treatment of patients with vertebroneurological and spinal pathology. For this purpose course of successive alternating perineural radicular paravertebral blockades with medicinal mixtures is carried out. On the first day blockades are performed with mixture of 1.0 ml of 0.05% solution of cyanocobalamin (vitamin B12) and 40.0 ml of 0.5% solution of Novocain. The following day blockades are performed with mixture of 1.0 ml 2.5% solution of dimephosphon and 40.0 ml 0.5% solution of Novocain. Treatment course constitutes from 10 to 14 days. ^ EFFECT: method allows to increase treatment efficiency considerably due to activation of metabolic processes and microcirculation in pathologic focus and around it as a result of Novocain and cyanocobalamin action, which in turn prepares spinal marrow and its roots to further dimephosphon impact. ^ 1 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2454961-C1
priorityDate 2008-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415822033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551195
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743321
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449288622
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507084
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122179
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7058172
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5795

Total number of triples: 25.